
Evelo Biosciences Inc is a biotechnology business based in the US. Evelo Biosciences shares (EVLO) are listed on the NASDAQ and all prices are listed in US Dollars. Evelo Biosciences employs 122 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Evelo Biosciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EVLO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Evelo Biosciences stock price (NASDAQ: EVLO)
Use our graph to track the performance of EVLO stocks over time.Evelo Biosciences shares at a glance
Latest market close | $2.15 |
---|---|
52-week range | $1.42 - $14.20 |
50-day moving average | $2.15 |
200-day moving average | $5.13 |
Wall St. target price | $17.75 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.32 |
Buy Evelo Biosciences shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Evelo Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Evelo Biosciences price performance over time
Historical closes compared with the close of $2.15 from 2022-07-01
1 week (2022-06-27) | -3.15% |
---|---|
1 month (2022-06-02) | -19.48% |
3 months (2022-04-04) | -39.44% |
6 months (2022-01-03) | -67.57% |
1 year (2021-07-02) | -83.38% |
---|---|
2 years (2020-07-02) | -57.26% |
3 years (2019-07-03) | 8.55 |
5 years (2017-06-30) | N/A |
Evelo Biosciences financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -68.83% |
Return on equity TTM | -348.67% |
Profit margin | 0% |
Book value | $0.16 |
Market capitalisation | $232 million |
TTM: trailing 12 months
Evelo Biosciences share dividends
We're not expecting Evelo Biosciences to pay a dividend over the next 12 months.
Evelo Biosciences share price volatility
Over the last 12 months, Evelo Biosciences's shares have ranged in value from as little as $1.419 up to $14.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evelo Biosciences's is 1.7688. This would suggest that Evelo Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Evelo Biosciences overview
Evelo Biosciences, Inc. , a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated investigational oral biologic, which is in Phase 1b for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. .
Evelo Biosciences in the news
Bullish Evelo Biosciences, Inc. (NASDAQ:EVLO) insiders were rewarded last week as their US$575k investment inflated to US$799k
Frequently asked questions
What percentage of Evelo Biosciences is owned by insiders or institutions?Currently 0.129% of Evelo Biosciences shares are held by insiders and 71.953% by institutions. How many people work for Evelo Biosciences?
Latest data suggests 122 work at Evelo Biosciences. When does the fiscal year end for Evelo Biosciences?
Evelo Biosciences's fiscal year ends in December. Where is Evelo Biosciences based?
Evelo Biosciences's address is: 620 Memorial Drive, Cambridge, MA, United States, 02139 What is Evelo Biosciences's ISIN number?
Evelo Biosciences's international securities identification number is: US2997341035 What is Evelo Biosciences's CUSIP number?
Evelo Biosciences's Committee on Uniform Securities Identification Procedures number is: 299734103
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert